Hillstream BioPharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $9,455,220.
Profit Margin
| 2019 | 0 | -1.17M | |
|---|---|---|---|
| 2020 | 0 | -2.37M | |
| 2021 | 0 | -3.03M | |
| 2022 | 0 | -8.47M | |
| 2023 | 0 | -9.31M |
HILS Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||
Research and development | 3.55M | 2.27M | 1.84M | 847.27K | 368.73K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 9.45M | 6.88M | 3.20M | 1.51M | 994.53K |
Operating income | -9.45M | -6.88M | -3.20M | -1.80M | -1.42M |
Other income (expenses), net | 136.12K | -1.59M | 1.00M | -609.02K | -101.53K |
Income before tax | -9.31M | -8.47M | -2.20M | -2.41M | -1.52M |
Income tax expense | 0 | 0 | 831.27K | -42.66K | -354.32K |
Net income | -9.31M | -8.47M | -3.03M | -2.37M | -1.17M |
Earnings per share | |||||
Basic EPS | -7.14 | -0.75 | -0.3 | -0.21 | -0.1 |
Diluted EPS | -7.14 | -0.75 | -0.3 | -0.21 | -0.1 |
| Data source | Data source | Data source |